Business Context and Reporting Period
This Form 8-K reports on the results of the 2023 Annual Meeting of Stockholders held by iRhythm Technologies, Inc. on May 24, 2023. The record date for the meeting was March 30, 2023. Holders of 29,240,639 shares, representing approximately 96.0% of the common stock entitled to vote, were present in person or by proxy, constituting a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Proposal 1 – Election of Directors: All seven nominees were elected to serve until the 2024 Annual Meeting.
- Cathleen Noel Bairey Merz, M.D.: 27,044,146 votes for.
- Quentin S. Blackford: 26,735,810 votes for.
- Bruce G. Bodaken: 19,685,233 votes for (notable dissent with 8,085,132 votes withheld).
- Karen Ling: 27,364,418 votes for.
- Mark J. Rubash: 27,122,720 votes for.
- Ralph Snyderman, M.D.: 26,841,665 votes for.
- Abhijit Y. Talwalkar: 24,563,707 votes for.
- Proposal 2 – Ratification of Auditors: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified with 29,174,545 votes for and 54,976 votes against.
- Proposal 3 – Executive Compensation: The advisory vote to approve named executive officer compensation passed with 24,771,355 votes for and 2,982,847 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to disclose the outcomes of the stockholder vote.
Important Facts for Investors to Verify
- Verify the specific reasons for the significant number of votes withheld for director nominee Bruce G. Bodaken (8,085,132 votes withheld) compared to other nominees.
- Confirm the total number of shares outstanding as of the record date to contextualize the 96.0% participation rate.
- Review the definitive proxy statement filed on April 12, 2023, for detailed background on the director nominees and executive compensation rationale.